Get started
Author

Mahmoud Elkazzaz

Observed names: Elkazzaz, Mahmoud, Elkazzaz, Mahmoud Ramadan, Mahmoud Ramadan Elkazzaz, Mahmoud El Kazzaz, Mahmoud Elkazzaz (11371806), Mahmoud Ramadan Elkazzaz, Mahmoud elkazzaz, mahmoud Elkazzaz, mahmoud ramadan elkazzaz
Observed institutions: Northwestern University, Damietta University, Kafrelsheikh University, Cairo University, Mansoura University, Al-Azhar University, Universidade Federal de Alfenas, King Saud University, Ministry of Health, Ministry of Health and Population
ORCID: 0000-0003-3703-520X
Observed ORCID: 0000-0003-3703-520X
OpenAlex ID: A5023505182
In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19
2022 · Mahmoud Elkazzaz, Amr Ahmed, et al. · Vaccines · 18
PDF
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
2023 · Israa M. Shamkh, Mahmoud Elkazzaz, et al. · Current Pharmaceutical Design · 5
13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial
2022 · Mahmoud Elkazzaz, Yousry Esam-Eldin Abo-Amer, et al. · medRxiv · 5
PDF
In silico discovery of GPCRSs and GnRHRs as Novel SARS-CoV-2 binding receptors, the Scientific Breakthrough that could explain the observed High cortisol, Appetite loss, Ansomnia and Hypogonadism, as well as Hypothyroidism, Retinol deficiency and menstrual disturbances among SARS-COV-2 patients.
2021 · Mahmoud Ramadan Elkazzaz, Amr Ahmed, et al. · Research Square · 5
Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research.
2021 · Mahmoud Ramadan Elkazzaz, Tamer Haydara, et al. · Research Square · 5
PDF
Crosstalk among strenuous exercise, IL-6 and S-Protein Based Vaccines for COVID-19 may explain the rare adverse effects of myocarditis and thrombosis in recently vaccinated young people. A prospective observational study.
2021 · Mahmoud Elkazzaz, Saleh Alofi, et al. · Research Square · 4
PDF
STRA6, as A Novel Binding Receptor of COVID-19, A Breakthrough That could Explain COVID-19 Symptoms with Unknown Aetiology.
2021 · Mahmoud Elkazzaz, Tamer Haydara, et al. · Research Square · 4
Natural phytochemicals, Phenformin, and Docosahexaenoic acid (DHA) as a Novel Inhibitors of IL-6 and ACE2 receptors, a Therapeutic Strategy for targeting COVID-19 Cell Entry and Cytokine Storm. An insilico Approach
2021 · Amr Kamel Khalil Ahmed, Mahmoud Elkazzaz · Research Square · 3
PDF
STRA6 (vitamin A receptor), as a Novel binding receptor of COVID-19 (A breakthrough)
2021 · Mahmoud Elkazzaz, Tamer Haydara, et al. · Research Square · 3
PDF
STRA6 (vitamin A receptor), as a Novel binding receptor of COVID-19
2021 · Mahmoud Elkazzaz, Amr Kamel Khalil Ahmed, et al. · 3
PDF
In silico Discovering STRA 6 Vitamin A Receptor, as a Novel Binding Receptor of COVID-19
2023 · Mahmoud Elkazzaz, Amr Ahmed, et al. · Indian Journal of Pharmaceutical Education and Research · 2
PDF
Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: molecular docking, dynamics, & STRING protein-protein network analysis
2023 · Mahmoud Elkazzaz, Shahid Ullah, et al. · Informatics in Medicine Unlocked · 1
Role of Zinc and Zinc Ionophores in Brain Health and Depression Especially during the COVID-19 Pandemic
2022 · Amr Ahmed, Amr Ghit, et al. · IntechOpen eBooks · 1
PDF
Could the candidate causal gene (LZTFL1) identified by Oxford University scientists, which doubles the risk of COVID-19-related respiratory failure, be used to boost the Weak immunogenicity of COVID-19 mRNA vaccines in patients with B-cell chronic lymphocytic leukemia (CLL)???. A double edged sward
2021 · Mahmoud Ramadan Elkazzaz, Yousry Esam-Eldin Abo-Amer, et al. · Research Square · 1
Are babies of vaccinated Pregnant and lactating mothers with ChAdOx1 AstraZeneca covid vaccine more risk for zinc deficiency and SCID disease.
2021 · Amr Kamel Khalil Ahmed, Mahmoud Elkazzaz · 1
PDF
Heat Stroke and Hyperosmolar Hyperglycemia State: Two Faces of the Same Coin (Dehydration) in the Hajj Journey - How to Reduce Deaths Among Pilgrims
2024 · Amr Ahmed, Maher M. Akl, et al. · Qeios
PDF
Can Intranasal insulin and Cholinergic agonist improve PostCovid-19 Cognition Impairment?
2023 · Amr kamel Ahmed, Mahmoud Elkazzaz, et al. · Advanced Pharmaceutical Bulletin
PDF
WITHDRAWN: Natural Phytochemicals, Phenformin, and Docosahexaenoic Acid (DHA) as Novel Inhibitors of Leukotriene B4 and ACE2 Receptors, a Therapeutic Strategy for Targeting COVID-19 Cell Entry and Cytokine Storm (An In-silico Approach)
2023 · Amr Ahmed, Ishrat Rahman, et al. · Letters in Drug Design & Discovery
Insilico discovering of STRA6 as a Novel Binding Receptor of Human Immunodeficiency (HIV)
2023 · Mahmoud Elkazzaz, Amr Ahmed, et al. · Research Square
STRA6 as a Novel Binding Receptor of Human Immunodeficiency Virus (HIV) May Explain Progressive Loss of CD4 T Cell Population and Thymic Dysfunction in HIV Patients
2023 · Mahmoud Ramadan Elkazzaz, Amr Ahmed, et al. · SSRN Electronic Journal
Corrigendum to “Inhibition of colorectal cancer targets IL-6, CTLA-4, & B7-2 by Tislelizumab: Molecular docking, dynamics, & STRING protein-protein network analysis” [Inform Med Unlocked 41 (2023) 101323]
2023 · Mahmoud Elkazzaz, Mahmoud Abdalrahman, et al. · Informatics in Medicine Unlocked
In Silico binding of human immunodeficiency virus (HIV) with STRA6 could explain the mystery of the immunodeficiency caused by HIV infection. An exciting breakthrough in molecular docking and Virology
2022 · Mahmoud Elkazzaz, Abdullah Haikal, et al. · Research Square
PDF
In Silico Inhibition of Three Cancer Inducing Receptors, IL-6, CTLA-4, and B7-2 by Dostarlimab may explain the 100% Complete Recovery Rate in MMRd Locally Advanced Rectal Cancer seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial. A Cancer Therapy Breakthrough.
2022 · mahmoud Elkazzaz, Abdullah Haikal, et al. · Research Square
PDF
In Silico Inhibition of three Cancer Inducing Receptors, IL-6, CTLA-4, and B7-2 by Dostarlimab may explain the 100% Complete Recovery Rate in MMRd Locally Advanced Rectal Cancer seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial. A Cancer Therapy Breakthrough.
2022 · mahmoud Elkazzaz, Abdullah Haikal, et al. · Research Square
In silico discovery of GPCRSs and GnRHRs as Novel SARS-CoV-2 binding receptors, the Scientific Breakthrough that could explain neuroendocrine disorders among SARS-COV-2 patients.
2022 · Mahmoud Ramadan Elkazzaz, Amr Ahmed, et al. · Research Square
PDF
Works count: 58
Citation count: 61
H-index: 5
I10-index: 1
Year
Topic
Type